Literature DB >> 30528492

Haptoglobin levels are influenced by Hp1-Hp2 polymorphism, obesity, inflammation, and hypertension in type 2 diabetes mellitus.

Kathryna Fontana Rodrigues1, Nathalia Teixeira Pietrani1, Laura Machado Lara Carvalho1, Adriana Aparecida Bosco2, Valéria Cristina Sandrim3, Cláudia Natália Ferreira4, Karina Braga Gomes5.   

Abstract

BACKGROUND: Type 2 diabetes mellitus (T2DM) is an inflammatory condition associated to obesity and increased oxidative stress. Haptoglobin (Hp) is an acute phase reactant that scavenges extracorpuscular hemoglobin from circulation and prevents heme-iron oxidative damage.
OBJECTIVE: To assess the association between Hp levels and Hp1-Hp2 gene polymorphism and clinical and laboratory parameters in patients with T2DM.
METHODS: The study sample consisted of 102 T2DM patients and 62 controls. Hp plasma levels were measured using an ELISA assay, and Hp genotyping was performed using a specific two-step allelic polymerase chain reaction.
RESULTS: Hp levels were higher in T2DM patients as compared to controls (p=0.005). T2DM patients with high blood pressure had higher Hp levels than patients without this comorbidity (p=0.021). Obese T2DM patients had higher Hp levels as compared to obese controls (p=0.009) and to non-obese T2DM patients (p=0.003). The Hp1-Hp1 genotype was showed to be associated to T2DM according to additive (OR=3.038, 95% CI 1.127-8.192; p=0.036) and dominant model (OR=0.320, 95% CI 0.118-0.839; p=0.010), but Hp2 allele carriers contributed with higher Hp levels in T2DM as compared to controls. Waist circumference (p=0.002), BMI (p=0.001), and IL-6 (p=0.012), and hs-CRP (p=0.001) levels positively correlated with Hp levels in the T2DM group.
CONCLUSION: These results suggest that Hp levels are influenced by Hp1-Hp2 polymorphism, obesity, inflammatory status, and high blood pressure in T2DM.
Copyright © 2018 SEEN y SED. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus tipo 2; Haptoglobin; Haptoglobina; Inflamación; Inflammation; Obesidad; Obesity; Polimorfismos; Polymorphisms; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2018        PMID: 30528492     DOI: 10.1016/j.endinu.2018.07.008

Source DB:  PubMed          Journal:  Endocrinol Diabetes Nutr (Engl Ed)        ISSN: 2530-0180            Impact factor:   1.417


  2 in total

1.  Hemopexin: A Novel Anti-inflammatory Marker for Distinguishing COPD From Asthma.

Authors:  Natasha A Winter; Peter G Gibson; Michael Fricker; Jodie L Simpson; Peter A Wark; Vanessa M McDonald
Journal:  Allergy Asthma Immunol Res       Date:  2021-05       Impact factor: 5.764

2.  Prospection of plasma proteins as biomarkers for diabetes mellitus monitoring.

Authors:  Liliane de Paula Silva; Fabiane Gomes de Moraes Rego; Geraldo Picheth; Marcelo Müller-Santos; Dayane Alberton
Journal:  J Diabetes Metab Disord       Date:  2021-03-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.